Methylphenidate-Induced Psychosis in Adult Attention-Deficit/Hyperactivity Disorder: Report of 3 New Cases and Review of the Literature
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We present 3 new cases of psychotic symptoms in patients with adult attention-deficit/hyperactivity disorder while regularly treated with a stimulant therapy with methylphenidate. METHODS: Existing literature about this theme is reviewed, and potential mechanisms are discussed. RESULTS AND CONCLUSIONS: Medication with methylphenidate should be avoided in patients with vulnerability to schizophrenia and in drug addiction, but reported cases without these risk factors demonstrate that a careful and regular psychiatric monitoring is essential in all patients treated with methylphenidate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Clinical Perspective of Attention-Deficit/Hyperactivity Disorder Into Adulthood
Wilens, T. E., & Dodson, W. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1003 · Cited by 274
Cited by
Dalsgaard, S., Mortensen, P. B., Frydenberg, M., Maibing, C. M., Nordentoft, M., & Thomsen, P. H. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2013.06.004 · Cited by 121
“on the emergence of psychotic symptoms in vulnerable hyperactive children, due to stimulant treatment [24,37,43,62].”
BackgroundNg, C. G., Boks, M. P. M., Roes, K. C. B., Zainal, N. Z., Sulaiman, A. H., Tan, S. B., & de Wit, N. J. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.01.016 · Cited by 52
“This is of particular concern in patients with a history of epilepsy or those with preexisting psychosis (Tan and Appleton, 2005; Kraemer et al., 2010).”
BackgroundGroenman, A. P., Schweren, L. J. S., Dietrich, A., & Hoekstra, P. J. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1301928 · Cited by 46
Metadata
- Authors
- Kraemer, M., Uekermann, J., Wiltfang, J., & Kis, B.
- Venue
- Clinical Neuropharmacology
- Published
- 2010-07
- Volume
- 33
- Issue
- 4
- Pages
- 204-206
- ISSN
- 0362-5664 (ISSN-L)
- OpenAlex
- W2080134429
- Cited by
- 62
- References
- 1
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.